154934-99-3 Usage
Description
2-Chloro-4-(trifluoromethyl)pyrimidine-5-carbonyl Chloride is an organic compound characterized by its colorless liquid appearance. It is a derivative of pyrimidine, a heterocyclic compound with potential applications in various fields due to its unique chemical properties.
Uses
Used in Pharmaceutical Industry:
2-Chloro-4-(trifluoromethyl)pyrimidine-5-carbonyl Chloride is used as an active pharmaceutical ingredient for the treatment of Rett Syndrome, a genetic neurological disorder that affects cognitive, sensory, motor, and autonomic function. It is also utilized in the treatment of acute coronary syndrome and related conditions, where it may help improve cardiovascular health and reduce the risk of heart-related complications.
Used in Agrochemical Industry:
In the agrochemical industry, 2-Chloro-4-(trifluoromethyl)pyrimidine-5-carbonyl Chloride is used as an anti-microbial agent. Its application in this field is aimed at controlling the growth of harmful microorganisms that can negatively impact crop yields and quality. By incorporating this compound into agrochemical products, it can help protect crops from diseases and pests, ultimately contributing to increased agricultural productivity and food security.
Check Digit Verification of cas no
The CAS Registry Mumber 154934-99-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,4,9,3 and 4 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 154934-99:
(8*1)+(7*5)+(6*4)+(5*9)+(4*3)+(3*4)+(2*9)+(1*9)=163
163 % 10 = 3
So 154934-99-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H8FNO4/c1-13-6-4-3-5(10(11)12)8(14-2)7(6)9/h3-4H,1-2H3
154934-99-3Relevant articles and documents
Inhibitors of NF-kappaB and AP-1 gene expression: SAR studies on the pyrimidine portion of 2-chloro-4-trifluoromethylpyrimidine-5-[N-(3', 5'-bis(trifluoromethyl)phenyl)carboxamide].
Palanki,Erdman,Gayo-Fung,Shevlin,Sullivan,Goldman,Ransone,Bennett,Manning,Suto
, p. 3995 - 4004 (2007/10/03)
We investigated the structure-activity relationship studies of N-[3, 5-bis(trifluoromethyl)phenyl][2-chloro-4-(trifluoromethyl)pyrimidin-5 -yl]carboxamide (1), an inhibitor of transcription mediated by both NF-kappaB and AP-1 transcription factors, with the goal of improving its potential oral bioavailability. Compounds were examined for cell-based activity, were fit to Lipinski's rule of 5, and were examined for potential gastrointestinal permeability using the intestinal epithelial cell line, Caco-2. Selected groups were substituted at the 2-, 4-, and 5-positions of the pyrimidine ring using solution-phase combinatorial methodology. The introduction of a fluorine in the place of 2-chlorine of 1 resulted in a compound with comparable activity. However, other substitutions at the 2-position resulted in a loss of activity. The trifluoromethyl group at the 4-position could be replaced with a methyl, ethyl, chlorine, or phenyl without a substantial loss of activity. The carboxamide group at the 5-position is critical for activity. If it was moved to the 6-position, the activity was lost. The 2-methyl analogue of 1 (81) showed comparable in vitro activity and improved Caco-2 permeability compared to 1.
